These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

807 related items for PubMed ID: 29593044

  • 1. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M, Garcia-Minambres A, Dalmau J, Jiménez-Moyano E, Viciana P, Alejos B, Clotet B, Prado JG, Martinez-Picado J.
    J Virol; 2018 Jun 15; 92(12):. PubMed ID: 29593044
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG, Côrtes FH, Bello G, Teixeira SLM, Hoagland B, Grinsztejn B, Veloso VG, Guimarães ML, Morgado MG.
    Retrovirology; 2018 Sep 10; 15(1):62. PubMed ID: 30201008
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
    Vieira VA, Adland E, Grayson NE, Csala A, Richards F, Dacon C, Athavale R, Tsai MH, D'Souza R, Muenchhoff M, Bonsall D, Jooste P, Goulder PJR.
    J Virol; 2022 Jan 26; 96(2):e0153521. PubMed ID: 34757843
    [Abstract] [Full Text] [Related]

  • 6. Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection.
    Singh AK, Salwe S, Padwal V, Velhal S, Sutar J, Bhowmick S, Mukherjee S, Nagar V, Patil P, Patel V.
    Front Immunol; 2020 Jan 26; 11():182. PubMed ID: 32194543
    [Abstract] [Full Text] [Related]

  • 7. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y, Zhang TH, Dai L, Zheng X, Gorin AM, Oishi J, Wu TT, Yoshizawa JM, Li X, Yang OO, Martinez-Maza O, Detels R, Sun R.
    mBio; 2017 Nov 28; 8(6):. PubMed ID: 29184023
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB, Zaunders JJ, Yuan FF, Wang B, Learmont JC, Geczy AF, Saksena NK, McPhee DA, Gorry PR, Sullivan JS.
    Retrovirology; 2008 Dec 11; 5():112. PubMed ID: 19077215
    [Abstract] [Full Text] [Related]

  • 9. HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer+ Gag-Specific CD4+ T Cells in Chronic Clade C HIV-1 Infection.
    Laher F, Ranasinghe S, Porichis F, Mewalal N, Pretorius K, Ismail N, Buus S, Stryhn A, Carrington M, Walker BD, Ndung'u T, Ndhlovu ZM.
    J Virol; 2017 Apr 01; 91(7):. PubMed ID: 28077659
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, Keet IP, Eeftinck-Schattenkerk JK, Osterhaus AD, Schuitemaker H, Miedema F.
    J Exp Med; 1995 Apr 01; 181(4):1365-72. PubMed ID: 7699324
    [Abstract] [Full Text] [Related]

  • 11. Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function.
    Curriu M, Fausther-Bovendo H, Pernas M, Massanella M, Carrillo J, Cabrera C, López-Galíndez C, Clotet B, Debré P, Vieillard V, Blanco J.
    PLoS One; 2012 Apr 01; 7(2):e30330. PubMed ID: 22312424
    [Abstract] [Full Text] [Related]

  • 12. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
    Bailey JR, Williams TM, Siliciano RF, Blankson JN.
    J Exp Med; 2006 May 15; 203(5):1357-69. PubMed ID: 16682496
    [Abstract] [Full Text] [Related]

  • 13. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL, Tao I, Szeto S, Brumme CJ, Carlson JM, Chan D, Kadie C, Frahm N, Brander C, Walker B, Heckerman D, Harrigan PR.
    AIDS; 2008 Jul 11; 22(11):1277-86. PubMed ID: 18580606
    [Abstract] [Full Text] [Related]

  • 14. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A, Olvera A, Anmole G, Kuang XT, Cotton LA, Plana M, Brander C, Brockman MA, Brumme ZL.
    J Virol; 2015 Nov 11; 89(22):11557-71. PubMed ID: 26355081
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response.
    Piantadosi A, Chohan B, Panteleeff D, Baeten JM, Mandaliya K, Ndinya-Achola JO, Overbaugh J.
    AIDS; 2009 Mar 13; 23(5):579-87. PubMed ID: 19516110
    [Abstract] [Full Text] [Related]

  • 16. Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals.
    Klatt NR, Bosinger SE, Peck M, Richert-Spuhler LE, Heigele A, Gile JP, Patel N, Taaffe J, Julg B, Camerini D, Torti C, Martin JN, Deeks SG, Sinclair E, Hecht FM, Lederman MM, Paiardini M, Kirchhoff F, Brenchley JM, Hunt PW, Silvestri G.
    PLoS Pathog; 2014 Aug 13; 10(8):e1004345. PubMed ID: 25167059
    [Abstract] [Full Text] [Related]

  • 17. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA, MacMillan D, Reddy T, Novitsky V, Brumme ZL, Brockman MA, Ndung'u T, Mann JK.
    J Virol; 2018 Oct 01; 92(19):. PubMed ID: 29997209
    [Abstract] [Full Text] [Related]

  • 18. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection.
    Maenetje P, Riou C, Casazza JP, Ambrozak D, Hill B, Gray G, Koup RA, de Bruyn G, Gray CM.
    J Immunol; 2010 May 01; 184(9):4926-35. PubMed ID: 20363974
    [Abstract] [Full Text] [Related]

  • 19. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
    Betts MR, Krowka JF, Kepler TB, Davidian M, Christopherson C, Kwok S, Louie L, Eron J, Sheppard H, Frelinger JA.
    AIDS Res Hum Retroviruses; 1999 Sep 01; 15(13):1219-28. PubMed ID: 10480635
    [Abstract] [Full Text] [Related]

  • 20. Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected].
    Graf EH, Pace MJ, Peterson BA, Lynch LJ, Chukwulebe SB, Mexas AM, Shaheen F, Martin JN, Deeks SG, Connors M, Migueles SA, O'Doherty U.
    PLoS One; 2013 Sep 01; 8(8):e71879. PubMed ID: 23951263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.